サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729298

日本のゲノミクス市場レポート：コンポーネント、技術、用途、エンドユーザー、地域別、2025年～2033年

Japan Genomics Market Report by Component, Technology, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.00円
日本のゲノミクス市場レポート：コンポーネント、技術、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のゲノミクスの市場規模は2024年に22億7,100万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに73億3,300万米ドルに達し、2025年から2033年の間に13.9%の成長率（CAGR）を示すと予測しています。遺伝性疾患や病態の増加により、遺伝子検査やシークエンシングサービスの需要が高まっていることが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のゲノミクス市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のゲノミクス市場に与えた影響は？
  • 日本のゲノミクス市場のコンポーネント別区分は？
  • 日本のゲノミクス市場の技術別区分は？
  • 日本のゲノミクス市場の用途別区分は？
  • 日本のゲノミクス市場のエンドユーザー別の区分は？
  • 日本のゲノミクス市場のバリューチェーンにおける様々なステージとは？
  • 日本のゲノミクスの主な促進要因と課題は何か？
  • 日本のゲノミクス市場の構造と主要プレーヤーは？
  • 日本のゲノミクス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のゲノミクス市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のゲノミクス市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のゲノミクス市場：コンポーネント別の内訳

  • 製品
  • サービス

第7章 日本のゲノミクス市場：技術別の内訳

  • シーケンシング
  • マイクロアレイ
  • ポリメラーゼ連鎖反応
  • 核酸の抽出と精製
  • その他

第8章 日本のゲノミクス市場：用途別の内訳

  • 機能ゲノミクス
  • エピゲノミクス
  • バイオマーカーの発見
  • パスウェイ解析
  • その他

第9章 日本のゲノミクス市場：エンドユーザー別の内訳

  • 研究センター
  • 病院と診療所
  • 製薬およびバイオテクノロジー企業
  • その他

第10章 日本のゲノミクス市場：競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のゲノミクス市場：業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112025A15519

Japan genomics market size reached USD 2,271 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,333 Million by 2033, exhibiting a growth rate (CAGR) of 13.9% during 2025-2033. The increasing incidences of genetic diseases and conditions, which has enhanced the demand for genetic testing and sequencing services, are primarily driving the market.

Genomics refers to a branch of biology that focuses on studying the complete set of an organism's genes, known as its genome. It encompasses the analysis of an organism's DNA, including its sequence, structure, function, and variations. Genomics plays an essential role in understanding the genetic makeup of living organisms, from humans to plants and microbes. This field has far-reaching implications for various aspects of life sciences and healthcare. It enables researchers to unravel the genetic basis of diseases, identify potential drug targets, and develop personalized medicine approaches. Genomics also aids in the study of evolution by comparing genomes across species to trace common ancestry and evolutionary adaptations. Advancements in technology, such as high-throughput DNA sequencing, have revolutionized genomics, making it more accessible and affordable. As a result, genomics has led to breakthroughs in fields like genetics, medicine, agriculture, and conservation, offering insights into the fundamental building blocks of life and the potential to address complex biological questions and challenges.

Japan Genomics Market Trends:

The genomics market in Japan is being propelled forward by a multitude of compelling drivers. Firstly, the rapid advancements in sequencing technology have enabled the cost-effective analysis of an individual's entire genetic code, driving genomics into mainstream healthcare. Furthermore, the increasing prevalence of genetic diseases and the demand for personalized medicine have fostered a growing awareness of the potential benefits of genomics, thus boosting market growth. In addition to this, government initiatives and research funding in Japan have played a pivotal role in expanding the genomics market. Collaborative efforts between public and private sectors have resulted in extensive genome mapping projects and the sharing of genomic data, facilitating research and innovation. Concurrently, the rising adoption of genomics in agriculture, with applications like precision breeding and crop improvement, has opened up a substantial market opportunity. Moreover, the ever-evolving landscape of AI and data analytics has expedited the interpretation of complex genomic data, making it more accessible and actionable. These technologies have revolutionized drug discovery and development, further energizing the genomics market in Japan.

Japan Genomics Market Segmentation:

Component Insights:

  • Products
    • Instruments and Software
    • Consumables and Reagents
  • Services
    • Core Genomics Services
    • NGS-Based Services
    • Biomarker Translation Services
    • Computational Services
    • Others

Technology Insights:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Application Insights:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

End User Insights:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan genomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan genomics market?
  • What is the breakup of the Japan genomics market on the basis of component?
  • What is the breakup of the Japan genomics market on the basis of technology?
  • What is the breakup of the Japan genomics market on the basis of application?
  • What is the breakup of the Japan genomics market on the basis of end user?
  • What are the various stages in the value chain of the Japan genomics market?
  • What are the key driving factors and challenges in the Japan genomics?
  • What is the structure of the Japan genomics market and who are the key players?
  • What is the degree of competition in the Japan genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Genomics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Genomics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Genomics Market - Breakup by Component

  • 6.1 Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Instruments and Software
      • 6.1.3.2 Consumables and Reagents
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Services
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Core Genomics Services
      • 6.2.3.2 NGS-Based Services
      • 6.2.3.3 Biomarker Translation Services
      • 6.2.3.4 Computational Services
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Genomics Market - Breakup by Technology

  • 7.1 Sequencing
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Microarray
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Polymerase Chain Reaction
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Nucleic Acid Extraction and Purification
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2019-2024)
    • 7.5.2 Market Forecast (2025-2033)

8 Japan Genomics Market - Breakup by Application

  • 8.1 Functional Genomics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Epigenomics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Biomarkers Discovery
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Pathway Analysis
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2019-2024)
    • 9.5.2 Market Forecast (2025-2033)

9 Japan Genomics Market - Breakup by End User

  • 9.1 Research Centers
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2019-2024)
    • 9.4.2 Market Forecast (2025-2033)

10 Japan Genomics Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Genomics Market - Industry Analysis

  • 12.1 Drivers, Restraints and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix